Navigation Links
Minorities Less Likely to Use Hospice Care: Study

FRIDAY, June 29 (HealthDay News) -- Minority patients with heart failure are less likely to use hospice care than whites, new research finds.

Hospice provides palliative care for the terminally ill. The goal is to ease pain and discomfort, and to focus on quality of life as death approaches. Overall, use of hospice care is increasing, according to researchers from Indiana University School of Medicine.

Their study found that nonwhite Medicare patients with heart failure were 20 percent less likely to enroll in hospice than white patients. Nonwhite patients were also more likely to drop out of hospice care than whites.

"When considering end-of-life care options, it is important to consider hospice services at home, in nursing homes or in hospice facilities," study author Dr. Kathleen Unroe, a scientist with the Indiana University Center for Aging Research, said in a university news release. "Our findings highlight that there is a significant difference between how white patients and nonwhite patients and their families utilize hospice services."

The study, which looked at records on nearly 220,000 heart failure patients on Medicare, was published in the June issue of the American Heart Journal.

Nearly 1.6 million people received hospice services in 2010, according to the National Hospice and Palliative Care Organization. About 42 percent of all deaths in the United States were under the care of a hospice program in 2010.

More information

The U.S. National Institutes of Health provides more information on hospice care.

-- Mary Elizabeth Dallas

SOURCE: Indiana University School of Medicine, news release, June 25, 2012

Copyright©2012 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Minorities, Medicare Recipients Less Likely to Get Antidepressants
2. C-Section Babies May Be More Likely to Fail First Hearing Test
3. Car crash victims more likely to survive if taken directly to a trauma centre
4. Patients with PsA treated with ustekinumab are twice as likely to achieve acr20 vs. placebo
5. Depressed Teens Who Respond to Treatment Less Likely to Abuse Drugs
6. City kids more likely to have food allergies than rural ones
7. Patients taking certolizumab pegol are twice as likely to achievE ACR20 compared to placebo
8. Obese More Likely to Be Diagnosed With Advanced Thyroid Cancer
9. Genetic test identifies eye cancer tumors likely to spread
10. Individuals with dementia more likely to die at home than in nursing homes
11. Blacks Less Likely to Get Help on Scene After Cardiac Arrest: Study
Post Your Comments:
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from reveals that behind ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. ... The attorneys chosen by their peers for this recognition are considered among the top ... Shareholders received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Calif. , June 23, 2016 Any dentist ... many challenges of the current process. Many of them do ... of the technical difficulties and high laboratory costs involved. And ... to offer it at such a high cost that the ... it. Dr. Parsa Zadeh , founder of ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: